HomeTLIS • OTCMKTS
add
Talis Biomedical Corp
Previous close
$1.84
Year range
$1.04 - $2.00
Market cap
3.35M USD
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 7.98M | — |
Net income | -8.85M | — |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -9.49M | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 59.87M | — |
Total assets | 72.70M | — |
Total liabilities | 24.07M | — |
Total equity | 48.63M | — |
Shares outstanding | 1.82M | — |
Price to book | 0.07 | — |
Return on assets | -30.86% | — |
Return on capital | -33.41% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -8.85M | — |
Cash from operations | -11.33M | — |
Cash from investing | 84.00K | — |
Cash from financing | 0.00 | — |
Net change in cash | -11.25M | — |
Free cash flow | -9.31M | — |
About
Founded
2013
Headquarters
Website
Employees
99
